| |
| Device | FoundationOne Liquid CDx (F1 Liquid CDx) |
| Generic Name | Next generation sequencing oncology panel, somatic or germline variant detection system |
| Applicant | Foundation Medicine, Inc. 150 Second St. Cambridge, MA 02141 |
| PMA Number | P200006 |
| Supplement Number | S003 |
| Date Received | 09/30/2022 |
| Decision Date | 10/28/2022 |
| APCB Date | 05/26/2023 |
| Product Code |
PQP |
| Advisory Committee |
Pathology |
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Postapproval Study Protocol |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the termination of the post-approval study (PAS) protocol. |